Angel Biotechnology Turns To 6-month Profit – Quick Facts – Stock Markets Review

By admin

Angel Biotechnology Turns To 6-month Profit – Quick Facts
Stock Markets Review
(RTTNews) – Angel Biotechnology Holdings Plc (ABH.L) said its six-month profit attributable to equity shareholders was £0.11 million compared with a loss

and more »



categoriaBiotechnology commentoComments Off | dataJuly 19th, 2010

About...

This author published 8935 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research